TrialBritish journal of clinical pharmacology2017

Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis.

Esther J H Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.